Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 7 de 7
Filter
1.
Physiother Theory Pract ; : 1-8, 2022 Nov 03.
Article in English | MEDLINE | ID: mdl-36326710

ABSTRACT

BACKGROUND: The risk of injury in archery is supposedly low. However, relations between pain, shooting phases and types of bow have not been studied. OBJECTIVE: Understanding the biomechanical mechanisms of archery-related injuries. METHODS: Online survey for archers from all types of bow. Variables were analyzed using contingency tables and chi-squared tests. RESULTS: 396 surveys were completed. 36.9% of the archers had practiced archery for more than 10 years, 23.3% between 5 and 10 years. Olympic recurve bow was the most commonly used (38.2%), followed by traditional (23.3%) and compound (22.0%). 57.3% of the archers suffered some kind of injury during archery practice. Drawing shoulder (28.2%) and neck/back injuries (19.9%) were the most prevalent, preventing 50.3% of those who suffered them from continuing archery practice. There was a moderate association between drawing arm injuries and symptomatology in the drawing phase, especially in the shoulder region (0.55), elbow (0.20), and hand (0.13), and to a lesser extent in the neck/back (0.28). CONCLUSIONS: Our results show that injury chronicity is frequent on archery. Correlations between types of bow, phases of the shoot and areas of pain could be a starting point for future studies on the repercussions of different types of injuries in archery practice.

2.
Haemophilia ; 28(6): 1016-1021, 2022 Nov.
Article in English | MEDLINE | ID: mdl-35921236

ABSTRACT

INTRODUCTION: A complete functional assessment is essential to measure health status and treatment effects in patients with haemophilia. The Patient-Specific Functional Scale (PSFS) is a reliable, valid, simple and quick scale that measures physical function in patients with musculoskeletal disorders. However, the reliability and validity of the PSFS have not been evaluated in patients with haemophilia. AIM: The aim of this study was to validate the Patient-Specific Functional Scale in patients with haemophilia. METHODS: Twenty-eight patients with haemophilia participated in the study. They completed the PSFS and the Haemophilia Activity List (HAL) scales by telephone during an initial session, and then repeated the assessment in a follow-up session 1 week apart. Reliability was analysed by the internal correlation coefficient (ICC), the standard error of measurement (SEM) and the smallest detectable change (SDC). The concurrent validity of the PSFS was determined by correlating the initial score of the PSFS scale to the initial score of the HAL scale. Correlations were calculated by means of scatter plots and Pearson product-moment r correlation coefficient. RESULTS: ICC and SEM values showed excellent reliability for the PSFS scale, with a SDC of 1. A significant moderate correlation was found between the results of the PSFS and the HAL (r = .57, P < .001). CONCLUSION: The PSFS is a reliable and valid scale to measure the functionality of people with haemophilia.


Subject(s)
Hemophilia A , Musculoskeletal Diseases , Humans , Reproducibility of Results , Physical Therapy Modalities
3.
PLoS Negl Trop Dis ; 9(11): e0004226, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26588076

ABSTRACT

BACKGROUND: Aedes aegypti is a cosmopolite mosquito, vector of arboviruses. The worldwide studies of its insecticide resistance have demonstrated a strong loss of susceptibility to pyrethroids, the major class of insecticide used for vector control. French overseas territories such as French Guiana (South America), Guadeloupe islands (Lesser Antilles) as well as New Caledonia (Pacific Ocean), have encountered such resistance. METHODOLOGY/PRINCIPAL FINDINGS: We initiated a research program on the pyrethroid resistance in French Guiana, Guadeloupe and New Caledonia. Aedes aegypti populations were tested for their deltamethrin resistance level then screened by an improved microarray developed to specifically study metabolic resistance mechanisms. Cytochrome P450 genes were implicated in conferring resistance. CYP6BB2, CYP6M11, CYP6N12, CYP9J9, CYP9J10 and CCE3 genes were upregulated in the resistant populations and were common to other populations at a regional scale. The implication of these genes in resistance phenomenon is therefore strongly suggested. Other genes from detoxification pathways were also differentially regulated. Screening for target site mutations on the voltage-gated sodium channel gene demonstrated the presence of I1016 and C1534. CONCLUSION /SIGNIFICANCE: This study highlighted the presence of a common set of differentially up-regulated detoxifying genes, mainly cytochrome P450 genes in all three populations. GUA and GUY populations shared a higher number of those genes compared to CAL. Two kdr mutations well known to be associated to pyrethroid resistance were also detected in those two populations but not in CAL. Different selective pressures and genetic backgrounds can explain such differences. These results are also compared with those obtained from other parts of the world and are discussed in the context of integrative research on vector competence.


Subject(s)
Aedes/drug effects , Insecticide Resistance , Insecticides/pharmacology , Nitriles/pharmacology , Pyrethrins/pharmacology , Aedes/genetics , Animals , Cytochrome P-450 Enzyme System/genetics , Female , French Guiana , Gene Expression Profiling , Guadeloupe , Microarray Analysis , Mutant Proteins/genetics , New Caledonia , Voltage-Gated Sodium Channels/genetics
4.
Bioorg Med Chem ; 21(2): 560-8, 2013 Jan 15.
Article in English | MEDLINE | ID: mdl-23219855

ABSTRACT

Many viral infections are associated with the development of immunopathologies and autoimmune diseases, which are of difficult treatment and for which no vaccines are yet available. Obtaining compounds that conjugate both antiviral and immunomodulatory activities in the same molecule would be very useful for the prevention and/or treatment of these immunopathologies. The compound (22S,23S)-22,23-dihydroxystigmast-4-en-3-one (compound 1) displays anti-Herpes simplex virus type 1 activity in vitro and reduces the incidence of herpetic stromal keratitis (HSK) in mice, a chronic inflammatory syndrome induced by ocular HSV-1 infection. In the present study, compound 1 showed opposite immunomodulatory properties in vitro. It induced the release of pro-inflammatory cytokines in HSV-1-infected epithelial cells of ocular origin, and significantly reduced the production of these cytokines in LPS-activated macrophages. RNA microarrays revealed various overexpressed and repressed genes in compound 1 treated infected epithelial cells and activated macrophages, many of which are associated with innate immune responses and inflammatory processes. These immunomodulatory properties of compound 1, together with its previously reported antiviral activity, make it a potential drug for the treatment of HSK and many other immunopathologies of viral and non-viral origin.


Subject(s)
Antiviral Agents/pharmacology , Cholestenones/chemistry , Herpesvirus 1, Human/drug effects , Immunologic Factors/chemistry , Stigmasterol/analogs & derivatives , Animals , Antiviral Agents/chemistry , Antiviral Agents/therapeutic use , Cell Line , Cell Survival/drug effects , Cholestenones/pharmacology , Cholestenones/therapeutic use , Corneal Stroma/cytology , Corneal Stroma/virology , Cytokines/genetics , Cytokines/metabolism , Epithelial Cells/cytology , Epithelial Cells/metabolism , Epithelial Cells/virology , Gene Expression Profiling , Humans , Immunologic Factors/pharmacology , Immunologic Factors/therapeutic use , Keratitis, Herpetic/drug therapy , Keratitis, Herpetic/immunology , Keratitis, Herpetic/veterinary , Mice , NF-kappa B/genetics , NF-kappa B/metabolism , Stigmasterol/chemistry , Stigmasterol/pharmacology , Stigmasterol/therapeutic use , Transcriptional Activation/drug effects
5.
J Appl Genet ; 53(1): 99-106, 2012 Feb.
Article in English | MEDLINE | ID: mdl-21952730

ABSTRACT

The white coat colour of sheep is an important economic trait. For unknown reasons, some animals are born with, and others develop with time, black skin spots that can also produce pigmented fibres. The presence of pigmented fibres in the white wool significantly decreases the fibre quality. The aim of this work was to study gene expression in black spots (with and without pigmented fibres) and white skin by microarray techniques, in order to identify the possible genes involved in the development of this trait. Five unrelated Corriedale sheep were used and, for each animal, the three possible comparisons (three different hybridisations) between the three samples of interest were performed. Differential gene expression patterns were analysed using different t-test approaches. Most of the major genes with well-known roles in skin pigmentation, e.g. ASIP, MC1R and C-KIT, showed no significant difference in the gene expression between white skin and black spots. On the other hand, many of the differentially expressed genes (raw P-value < 0.005) detected in this study, e.g. C-FOS, KLF4 and UFC1, fulfil biological functions that are plausible to be involved in the formation of black spots. The gene expression of C-FOS and KLF4, transcription factors involved in the cellular response to external factors such as ultraviolet light, was validated by quantitative polymerase chain reaction (PCR). This exploratory study provides a list of candidate genes that could be associated with the development of black skin spots that should be studied in more detail. Characterisation of these genes will enable us to discern the molecular mechanisms involved in the development of this feature and, hence, increase our understanding of melanocyte biology and skin pigmentation. In sheep, understanding this phenomenon is a first step towards developing molecular tools to assist in the selection against the presence of pigmented fibres in white wool.


Subject(s)
Gene Expression Profiling , Sheep, Domestic/genetics , Skin Pigmentation/genetics , Agouti Signaling Protein/genetics , Animals , Cyclic AMP Response Element-Binding Protein/genetics , Gene Expression Regulation , Genes, fos , Kruppel-Like Factor 4 , Kruppel-Like Transcription Factors/genetics , Melanocytes/cytology , Oligonucleotide Array Sequence Analysis/methods , Phenotype , Proto-Oncogene Proteins c-kit/genetics , Receptor, Melanocortin, Type 1/genetics , Reverse Transcriptase Polymerase Chain Reaction , Sheep, Domestic/physiology , Skin/cytology , Skin Pigmentation/physiology , Transcription Factors/genetics , Ubiquitin-Conjugating Enzymes/genetics , Wool/physiology
6.
PLoS Negl Trop Dis ; 5(1): e931, 2011 Jan 11.
Article in English | MEDLINE | ID: mdl-21264349

ABSTRACT

BACKGROUND: A century after its discovery, Chagas disease still represents a major neglected tropical threat. Accurate diagnostics tools as well as surrogate markers of parasitological response to treatment are research priorities in the field. The purpose of this study was to evaluate the performance of PCR methods in detection of Trypanosoma cruzi DNA by an external quality evaluation. METHODOLOGY/FINDINGS: An international collaborative study was launched by expert PCR laboratories from 16 countries. Currently used strategies were challenged against serial dilutions of purified DNA from stocks representing T. cruzi discrete typing units (DTU) I, IV and VI (set A), human blood spiked with parasite cells (set B) and Guanidine Hidrochloride-EDTA blood samples from 32 seropositive and 10 seronegative patients from Southern Cone countries (set C). Forty eight PCR tests were reported for set A and 44 for sets B and C; 28 targeted minicircle DNA (kDNA), 13 satellite DNA (Sat-DNA) and the remainder low copy number sequences. In set A, commercial master mixes and Sat-DNA Real Time PCR showed better specificity, but kDNA-PCR was more sensitive to detect DTU I DNA. In set B, commercial DNA extraction kits presented better specificity than solvent extraction protocols. Sat-DNA PCR tests had higher specificity, with sensitivities of 0.05-0.5 parasites/mL whereas specific kDNA tests detected 5.10(-3) par/mL. Sixteen specific and coherent methods had a Good Performance in both sets A and B (10 fg/µl of DNA from all stocks, 5 par/mL spiked blood). The median values of sensitivities, specificities and accuracies obtained in testing the Set C samples with the 16 tests determined to be good performing by analyzing Sets A and B samples varied considerably. Out of them, four methods depicted the best performing parameters in all three sets of samples, detecting at least 10 fg/µl for each DNA stock, 0.5 par/mL and a sensitivity between 83.3-94.4%, specificity of 85-95%, accuracy of 86.8-89.5% and kappa index of 0.7-0.8 compared to consensus PCR reports of the 16 good performing tests and 63-69%, 100%, 71.4-76.2% and 0.4-0.5, respectively compared to serodiagnosis. Method LbD2 used solvent extraction followed by Sybr-Green based Real time PCR targeted to Sat-DNA; method LbD3 used solvent DNA extraction followed by conventional PCR targeted to Sat-DNA. The third method (LbF1) used glass fiber column based DNA extraction followed by TaqMan Real Time PCR targeted to Sat-DNA (cruzi 1/cruzi 2 and cruzi 3 TaqMan probe) and the fourth method (LbQ) used solvent DNA extraction followed by conventional hot-start PCR targeted to kDNA (primer pairs 121/122). These four methods were further evaluated at the coordinating laboratory in a subset of human blood samples, confirming the performance obtained by the participating laboratories. CONCLUSION/SIGNIFICANCE: This study represents a first crucial step towards international validation of PCR procedures for detection of T. cruzi in human blood samples.


Subject(s)
Chagas Disease/diagnosis , DNA, Protozoan/blood , Parasitology/methods , Polymerase Chain Reaction/methods , Trypanosoma cruzi/isolation & purification , Chagas Disease/parasitology , Humans , International Cooperation , Sensitivity and Specificity , Trypanosoma cruzi/genetics
7.
Rev. méd. Urug ; 22(1): 17-21, mar. 2006. tab
Article in Spanish | LILACS | ID: lil-424154

ABSTRACT

Las nuevas técnicas de biología molecular aplicadas al diagnóstico genético y el uso de marcadores moleculares posibilitan el estudio de los mecanismos que subyacen en la predisposición individual y familiar a padecer determinadas enfermedades. Para llevar a cabo estos estudios, es necesario en primera instancia establecer cuál es la prevalencia de dichos marcadores en la población general. El estudio se realizó empleando una muestra de 108 individuos seleccionados por muestreo simple del banco de ADN de 500 individuos representativos de nuestra población, que pertenece al Departamento de Citogenética del Instituto de Investigaciones Biológicas Clemente Estable (IIBCE). Para establecer el genotipo del gen de la enzima convertidora de angiotensina (ECA) en cada una de las muestras, se amplificó un fragmento de ADN perteneciente al intrón 16 de este gen mediante la técnica de reacción en cadena de la polimerasa (PCR). El genotipo predominante en esta población control es el heterocigota I/D (50,9 por ciento), encontrándose el genotipo homocigota para la delección (D/D) (30,6 por ciento) en mayoría con respecto al genotipo homocigota para la inserción (I/I) (18,5 por ciento). Los resultados sugieren que existe, por tanto, un predominio del alelo D con respecto al alelo I en la población montevideana, habiéndose hallado diferencias significativas con respecto a poblaciones de origen asiático y americano, pero no con poblaciones europeas.


Subject(s)
Genetic Predisposition to Disease , Polymorphism, Genetic/genetics , Uruguay
SELECTION OF CITATIONS
SEARCH DETAIL
...